Viral hepatitis is a significant cause of disease and death globally. Yet powerful new medical tools to combat hepatitis C and E still reach only a tiny fraction of people who desperately need them, especially in low-resource and emergency settings.

To mark World Hepatitis Day (July 28th) we highlight recent MSF research on making these breakthrough products more widely accessible and simpler to use.

For hepatitis C, where groundbreaking antiviral drugs can cure nearly all patients, MSF is developing comprehensive, community-based models of care that offer rapid screening, diagnosis, and treatment under one roof. In some settings programs focus on the specific needs of highly vulnerable populations, such as people living in remote areas, forcibly displaced refugees, or those co-infected with HIV or TB or who inject drugs.

Turning to prevention, MSF is exploring ways to use the Hepatitis E vaccine more effectively in areas where poor sanitation and water quality regularly lead to outbreaks. Studies in a South Sudanese camp for internally displaced people are strengthening evidence for the vaccine’s feasibility, efficacy, safety and community acceptance, especially for pregnant women and their fetuses. Another report analyzes strategies for overcoming barriers to widespread vaccine adoption.

As we mark World Refugee Day (20 June 2022), over 100 million people globally are forcibly displaced from their home—the highest number ever recorded, according to the United Nations Refugee Agency. The health impacts of this displacement are dire: millions of people exposed to violence, infectious disease, and exclusion from health care during often-treacherous journeys or in detention centers and refugee camps.

Here we bring you a selection of MSF research aimed at better understanding and meeting the medical needs of populations along their migration route. Some studies describe the physical and psychological wounds our teams witness among specific populations—from unaccompanied minors to people detained under inhumane conditions in Libya or rescued from drowning after risking everything in perilous Mediterranean Sea crossings. Others assess ways to improve models of care for refugees with chronic diseases like hypertension and diabetes, or for tackling infectious diseases such as diphtheria and hepatitis E in overcrowded, unhygienic camps.